1. Home
  2. INBX vs CLBR Comparison

INBX vs CLBR Comparison

Compare INBX & CLBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBX
  • CLBR
  • Stock Information
  • Founded
  • INBX 2010
  • CLBR 2023
  • Country
  • INBX United States
  • CLBR United States
  • Employees
  • INBX N/A
  • CLBR N/A
  • Industry
  • INBX Biotechnology: Pharmaceutical Preparations
  • CLBR
  • Sector
  • INBX Health Care
  • CLBR
  • Exchange
  • INBX Nasdaq
  • CLBR Nasdaq
  • Market Cap
  • INBX 222.5M
  • CLBR 217.4M
  • IPO Year
  • INBX 2020
  • CLBR 2023
  • Fundamental
  • Price
  • INBX $16.21
  • CLBR $10.32
  • Analyst Decision
  • INBX Hold
  • CLBR
  • Analyst Count
  • INBX 1
  • CLBR 0
  • Target Price
  • INBX N/A
  • CLBR N/A
  • AVG Volume (30 Days)
  • INBX 47.7K
  • CLBR 72.1K
  • Earning Date
  • INBX 08-13-2024
  • CLBR 01-01-0001
  • Dividend Yield
  • INBX N/A
  • CLBR N/A
  • EPS Growth
  • INBX N/A
  • CLBR N/A
  • EPS
  • INBX 118.83
  • CLBR N/A
  • Revenue
  • INBX $1,687,000.00
  • CLBR N/A
  • Revenue This Year
  • INBX N/A
  • CLBR N/A
  • Revenue Next Year
  • INBX N/A
  • CLBR N/A
  • P/E Ratio
  • INBX $0.14
  • CLBR $132.33
  • Revenue Growth
  • INBX 24.26
  • CLBR N/A
  • 52 Week Low
  • INBX $10.80
  • CLBR $9.16
  • 52 Week High
  • INBX $18.95
  • CLBR $10.48
  • Technical
  • Relative Strength Index (RSI)
  • INBX 56.54
  • CLBR 65.00
  • Support Level
  • INBX $15.24
  • CLBR $10.23
  • Resistance Level
  • INBX $16.79
  • CLBR $10.27
  • Average True Range (ATR)
  • INBX 0.59
  • CLBR 0.02
  • MACD
  • INBX 0.02
  • CLBR 0.00
  • Stochastic Oscillator
  • INBX 62.56
  • CLBR 81.82

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

About CLBR Colombier Acquisition Corp. II

Colombier Acquisition Corp II is a blank check company.

Share on Social Networks: